NSC |
Compound |
Enrichment |
Correlation |
NSC 650021 |
Null |
0.0278435641331424 |
-0.10006074 |
NSC 653843 |
Null |
0.0278435641331424 |
-0.14365232 |
NSC 656889 |
XK-469 |
0.0278435641331424 |
0.24413532 |
NSC 657348 |
Null |
0.0278435641331424 |
0.006694839 |
NSC 668281 |
(-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine |
0.0278435641331424 |
0.29255233 |
NSC 670656 |
4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer |
0.0278435641331424 |
0.20587587 |
NSC 683125 |
2-Ethoxy-6-(O-methyl)hydroxyiminoestra-1,3,5(10)-trien-3,17.beta.-diol |
0.0278435641331424 |
-0.047250504 |
NSC 684480 |
7H-Pyrido[3,2-d][1]benzazepin-6-one, 2-(3-chlorophenyl)- 5,6-dihydro-4-phenyl- |
0.0278435641331424 |
-0.20980955 |
NSC 690266 |
ANTINEOPLASTIC-690266 |
0.0278435641331424 |
0.54231274 |
NSC 693984 |
Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-propynyl-, (E)- |
0.0278435641331424 |
0.6149726 |